{"filings":[{"id":1777196,"accession_number":"0001437749-26-023964","cik":1038277,"company_name":"RADNOSTIX INC","ticker":"INIS","form_type":"8-K","filed_at":"2026-07-21T20:54:47+00:00","items":["5.02","5.07","9.01"],"status":"ready","headline":"Shareholders approve 2026 Incentive Plan authorizing 12M shares; directors elected","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Annual meeting held July 16, 2026; quorum of 58.46% of outstanding shares represented.","All five director nominees elected with over 99% votes for each.","Ratification of Haynie & Company as independent auditor for FY2026 approved.","2026 Incentive Plan approved, authorizing up to 12M shares to replace expired 2015 plan.","Plan aims to attract, retain, and motivate employees, officers, directors, and service providers."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":41272168.80984952,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":1387797,"accession_number":"0001437749-26-022282","cik":1038277,"company_name":"RADNOSTIX INC","ticker":"INIS","form_type":"8-K","filed_at":"2026-07-01T20:08:34+00:00","items":["1.01","2.01","2.03","3.02","9.01"],"status":"ready","headline":"Radnostix acquires Lara System assets for $900K; issues $500K convertible note to related party","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Acquired Lara System and Ellexa Explorer assets from Lucerno Dynamics for $150K cash + $750K in stock (20-day VWAP).","Potential milestone payments: $500K stock upon Nuclear Medicine Clarification Act approval, $250K stock on Lara System placements, plus earnouts.","Issued $500K convertible promissory note to Kershner Grosso & Co. (owned by chairman) at 5% interest, convertible at $0.07/share, maturity 2031.","Amended historic notes (2013, 2018, 2019) totaling ~$1.62M: extended maturity to 2031, released liens, added conversion rights at $0.07 and forced conversion at $0.12 VWAP.","The note and amendments are related-party transactions approved by disinterested directors."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":41272168.80984952,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":553156,"accession_number":"0001437749-26-017929","cik":1038277,"company_name":"RADNOSTIX INC","ticker":"INIS","form_type":"8-K","filed_at":"2026-05-20T19:36:45+00:00","items":["3.03","5.03","9.01"],"status":"ready","headline":"Radnostix extends Series C Preferred maturity to February 28, 2028","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Majority of Series C Preferred holders approved extension of maturity date by one year to February 28, 2028.","All other terms of the Series C Preferred Stock remain unchanged.","Company filed Certificate of Amendment with Texas Secretary of State on May 19, 2026."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":41272168.80984952,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":100538,"accession_number":"0001437749-26-008319","cik":1038277,"company_name":"RADNOSTIX INC","ticker":"INIS","form_type":"8-K","filed_at":"2026-03-16T23:59:59+00:00","items":["1.02","8.01","9.01"],"status":"ready","headline":"Radnostix terminates $12.45M DUF6 plant sale to AFR; voluntary capsule recall","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["APA terminated mutually on March 11, 2026; AFR could not pay $12.45M balance by March 31, 2026.","AFR had paid $170K in non-refundable fees; no closing proceeds received by Radnostix.","Company sees asset appreciation, low buyer funding confidence; will evaluate DUF6 plant options.","Voluntary recall of Dibasic Sodium Phosphate Capsules (lots 2022-2025) for final capsule weight out of spec.","Estimated costs: $125K write-offs and refunds; further $75K inventory + $25K-$75K/week lost revenue thru Q2."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":41272168.80984952,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":116854,"accession_number":"0001437749-25-039001","cik":1038277,"company_name":"RADNOSTIX INC","ticker":"INIS","form_type":"8-K","filed_at":"2025-12-31T23:59:59+00:00","items":["5.03","8.01","9.01"],"status":"ready","headline":"International Isotopes changes name to Radnostix; ticker INIS unchanged","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["Name changed from International Isotopes Inc. to Radnostix, Inc. effective December 23, 2025.","Board approved the change on October 21, 2025; shareholders consented on November 25, 2025.","Rebranding reflects expanded focus on radioisotopes and theranostics for healthcare applications.","Common stock continues trading under symbol INIS on OTCQB; no action required from shareholders."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":41272168.80984952,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":116853,"accession_number":"0001437749-25-031242","cik":1038277,"company_name":"RADNOSTIX INC","ticker":"INIS","form_type":"8-K","filed_at":"2025-10-17T23:59:59+00:00","items":["5.02","5.03","9.01"],"status":"ready","headline":"International Isotopes enters CEO employment agreement, appoints Dr. Duke Fu as director, and amends bylaws","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["CEO Shahe Bagerdjian signs new employment agreement with $314,000 base salary, 5% annual increases, and 37,500,000 RSUs vesting at share price milestones up to $0.30.","Dr. Duke W. Fu appointed to board and audit committee; receives 250,000 RSUs per annual term starting July 11, 2026.","Bylaws amended to add advance notice procedures for shareholder business and director nominations, and provisions for indemnification and insurance.","Bylaws now allow postponement of special meetings and shareholder action by less-than-unanimous written consent."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":41272168.80984952,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":116852,"accession_number":"0001437749-25-031241","cik":1038277,"company_name":"RADNOSTIX INC","ticker":"INIS","form_type":"8-K","filed_at":"2025-10-17T23:59:59+00:00","items":["5.02","5.03","9.01"],"status":"ready","headline":"International Isotopes CEO Bagerdjian signs 5-year employment agreement; Dr. Fu appointed to board","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["CEO Shahe Bagerdjian's base salary set at $314K with automatic 5% annual increases through 2030 and up to $250K in milestone raises based on quarterly revenue hitting $3.75M–$25M.","Bagerdjian awarded 37.5M RSUs vesting in tranches at share prices of $0.10 to $0.30 over 60 consecutive calendar days; immediate vesting upon termination without cause or change of control.","Dr. Duke W. Fu, nuclear pharmacist executive, appointed to board and audit committee; receives 250K RSUs annually.","Bylaws amended: clarify special meeting business, add advance notice for shareholder proposals and director nominations, allow advisory directors, and update indemnification/insurance provisions."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":41272168.80984952,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":133295,"accession_number":"0001437749-25-022820","cik":1038277,"company_name":"RADNOSTIX INC","ticker":"INIS","form_type":"8-K","filed_at":"2025-07-16T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"International Isotopes shareholders approve reverse stock split, re-elect directors","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Shareholders approved amendment to certificate of formation for reverse stock split at ratio 1:50 to 1:275, with exact ratio set by Board.","All four director nominees elected: Robert Atcher, Shahe Bagerdjian, Christopher Grosso, Steve T. Laflin.","Ratification of Haynie & Company as independent auditor for FY2025, with ~324M votes for.","Advisory vote on executive compensation held every three years; 90.1% of votes cast in favor of triennial frequency.","Approx. 61.6% of outstanding shares represented at meeting, forming quorum."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":41272168.80984952,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":186051,"accession_number":"0001437749-24-030450","cik":1038277,"company_name":"RADNOSTIX INC","ticker":"INIS","form_type":"8-K","filed_at":"2024-10-02T23:59:59+00:00","items":["3.03","5.03","9.01"],"status":"ready","headline":"International Isotopes extends Series C Preferred maturity to Feb 28, 2027","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Majority of Series C Preferred stockholders approved a two-year maturity extension to February 28, 2027.","All other terms of the Series C Convertible Redeemable Preferred Stock remain unchanged.","Certificate of Amendment filed with Texas Secretary of State on September 26, 2024.","Approval received on September 25, 2024; filing reported on Form 8-K dated September 26, 2024."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.45,"calibrated_materiality_score":0.45,"market_cap_usd":41272168.80984952,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":202654,"accession_number":"0001437749-24-022768","cik":1038277,"company_name":"RADNOSTIX INC","ticker":"INIS","form_type":"8-K","filed_at":"2024-07-16T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"International Isotopes elects four directors, ratifies auditor at 2024 annual meeting","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["Shareholders elected Robert Atcher, Shahe Bagerdjian, Christopher Grosso, and Steve T. Laflin as directors for one-year terms.","Haynie & Company ratified as independent auditor for fiscal year ending December 31, 2024 with 268,868,853 votes for, 107,440 against.","Approximately 269 million shares voted, representing 51.4% of outstanding shares, constituting a quorum."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"market_cap_usd":41272168.80984952,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":238724,"accession_number":"0001437749-24-003529","cik":1038277,"company_name":"RADNOSTIX INC","ticker":"INIS","form_type":"8-K","filed_at":"2024-02-08T23:59:59+00:00","items":["1.01","7.01","9.01"],"status":"ready","headline":"International Isotopes sells depleted uranium deconversion assets to AFR for $12.5M","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Sale of DUF 6 plant assets to American Fuel Resources for $12.5M cash at closing, plus $50K prepayment.","Closing expected in 12–24 months, contingent on NRC license transfer and other conditions.","Company to focus on medical device and theranostics business lines; plans to strengthen balance sheet."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":41272168.80984952,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":273607,"accession_number":"0001515971-23-000105","cik":1038277,"company_name":"RADNOSTIX INC","ticker":"INIS","form_type":"8-K","filed_at":"2023-07-18T23:59:59+00:00","items":["5.02","5.07"],"status":"ready","headline":"CEO Steve Laflin to step down Sept 1; President Shahe Bagderjian named successor and joins board","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Steve Laflin resigns as CEO effective Sept 1, 2023 after 22 years; remains on board as director and consultant.","President Shahe Bagderjian appointed CEO effective Sept 1, 2023; also appointed to board (expanded from 3 to 4 directors).","At July 12 annual meeting, all three director nominees (Laflin, Grosso, Atcher) elected; auditor Haynie & Company ratified.","Bagderjian's CEO compensation per previously disclosed employment agreement; no separate board compensation."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":41272168.80984952,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":290611,"accession_number":"0001515971-23-000059","cik":1038277,"company_name":"RADNOSTIX INC","ticker":"INIS","form_type":"8-K","filed_at":"2023-05-10T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"International Isotopes appoints Shahe Bagerdjian as President effective May 8, 2023","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Shahe Bagerdjian, former GMS SVP Operations & Business Development, named President.","Base salary $285,000/year with annual $14k–$17k increases over 5-year term.","RSU grant of 6.5 million shares vesting over three years: 1.5M (2024), 2M (2025), 3M (2026).","Potential future CEO appointment would bring 2.5M fully-vested RSUs.","Relocation reimbursement up to $25,000; target cash bonus 20% of salary."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":41272168.80984952,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":311491,"accession_number":"0001515971-23-000019","cik":1038277,"company_name":"RADNOSTIX INC","ticker":"INIS","form_type":"8-K","filed_at":"2023-02-28T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"International Isotopes extends CEO Steve Laflin's term to Aug 2023, provides $25K transition bonus","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Amendment extends CEO Steve Laflin's employment agreement to August 31, 2023.","Upon transition to a new CEO, Laflin will receive a $25,000 bonus.","All other terms of the employment agreement remain unchanged.","Amendment executed on February 22, 2023, filed as Exhibit 10.1."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":41272168.80984952,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":330076,"accession_number":"0001515971-22-000211","cik":1038277,"company_name":"RADNOSTIX INC","ticker":"INIS","form_type":"8-K","filed_at":"2022-12-28T23:59:59+00:00","items":["3.03","5.03","9.01"],"status":"ready","headline":"International Isotopes extends Series C Preferred maturity to Feb 28, 2025","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Majority of Series C Preferred stockholders approved a two-year maturity extension.","New maturity date is February 28, 2025; all other terms unchanged.","Certificate of Amendment filed with Texas Secretary of State on December 28, 2022.","Extension avoids immediate conversion or redemption triggers for Series C Preferred."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":41272168.80984952,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":347636,"accession_number":"0001515971-22-000134","cik":1038277,"company_name":"RADNOSTIX INC","ticker":"INIS","form_type":"8-K","filed_at":"2022-07-19T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"Shareholders approve reverse stock split 1-for-20 to 1-for-150 at annual meeting","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Steve T. Laflin, Christopher Grosso, Robert Atcher re-elected as directors; each received >212M votes for.","Haynie & Company ratified as auditor for FY2022 with 263.1M for, 109k against, 545k abstain.","Advisory vote on executive compensation approved: 209.6M for, 2.6M against, 805k abstain.","Reverse stock split amendment approved (256.5M for, 6.4M against, 832k abstain); ratio set by board at 1:20 to 1:150."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":41272168.80984952,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":383854,"accession_number":"0001515971-22-000039","cik":1038277,"company_name":"RADNOSTIX INC","ticker":"INIS","form_type":"8-K","filed_at":"2022-02-22T23:59:59+00:00","items":["2.01","1.01","3.03","5.03","9.01"],"status":"ready","headline":"International Isotopes completes $4M asset sale to Pharmalogic; extends Series C Preferred maturity","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Completed sale of manufacturing equipment and sublease to Pharmalogic Idaho for $4.0M cash on Feb 18, 2022.","Series C Preferred Stock maturity extended by ~1 year to February 28, 2023, approved by majority of holders.","Certificate of Amendment filed with Texas Secretary of State on Feb 16, 2022 to reflect the extension.","The assets sold were acquired via a prior manufacturing and supply agreement termination."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":41272168.80984952,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":383853,"accession_number":"0001515971-22-000034","cik":1038277,"company_name":"RADNOSTIX INC","ticker":"INIS","form_type":"8-K","filed_at":"2022-02-16T23:59:59+00:00","items":["1.01","9.01"],"status":"ready","headline":"International Isotopes to sell manufacturing equipment and sublease to Pharmalogic for $4.0M cash","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Asset Purchase Agreement signed Feb 10, 2022; Pharmalogic Idaho, LLC to pay $4.0 million cash.","Assets include manufacturing equipment and a sublease from a terminated supply agreement.","Transaction expected to close on or around February 18, 2022."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":41272168.80984952,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":420634,"accession_number":"0001515971-21-000067","cik":1038277,"company_name":"RADNOSTIX INC","ticker":"INIS","form_type":"8-K","filed_at":"2021-07-14T23:59:59+00:00","items":["1.01","2.01","3.02","5.07","7.01","9.01"],"status":"ready","headline":"International Isotopes acquires remaining 75% of RadQual for $4.4M in stock; expects immediate accretion","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Acquired remaining 75% of RadQual for $4.4M, paying 40,176,236 shares at $0.11/share based on 60-day VWAP.","RadQual is a premier developer of nuclear medicine QC products; INIS had been contract manufacturer and manager since 2017.","Transaction expected to immediately increase shareholder equity, improve net profit margin, and be accretive.","RadQual launched several new products in 2021 including Symbia source, D-SPECT line source, and germanium rods.","At annual meeting, shareholders elected Laflin, Grosso, and Atcher as directors; ratified Haynie & Company as auditor."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":41272168.80984952,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null}],"next_cursor":null}